In the upcoming series of ground-breaking developments at Capebio, today we share this important milestone with our clients, stakeholders, partners and industry colleagues.This is to ensure the highest level of quality assurance, compliance and excellent customer experience.
Congratulations to our CEO Daniel Ndima for being one of the finalists for the upcoming All Africa Business Leaders Awards 2023, in the category: Innovator Of The Year 2023. Best of luck to you CEO.
#RichinDiversity#Innovation#AIinHealthcare#africa#biotechnology
Congratulations to @CAPEBIO™_SA.
Long-Term Commitment Award. A business that has demonstrated strong industry relationship-building the ability to build a strong management team and board, sustained but flexible focus on long-term vision and ongoing product development research
Join @NRF_SAASTA for an Indigenous Knowledge System webinar focusing on the “Role of Traditional Medicine in Modern Healthcare Systems”.
Date: 15 September 2022
Time: 10:00 to 12:00
Register here (Zoom): https://t.co/Z2juWaSnfx
#biotech#lifesciences#entrepreneur Biotechnology Start-Up CapeBio Technologies Seeks To Create Innovations That Improve The Quality Of Life In Africa https://t.co/3h0o2dhtJE, see more https://t.co/xLAAqNs6t5
Company Office: Founder of E Squared portfolio company CapeBio, Daniel Ndima, asked corporate South Africa, "Are we serious about ourselves and our future?" https://t.co/nG27Vx3OI4
Company Office: Founder of E Squared portfolio company CapeBio, Daniel Ndima, asked corporate South Africa, "Are we serious about ourselves and our future?" https://t.co/Aoaer22JpH
We really enjoyed the session too. Thanks SMME speakers @DK_Ndima @ajaylalu1 @CapeBioSA sharing great insights & also reps of big biz @phuthi_Malabie@bonang_mohale. I hope we can amplify & look at how we correct some of the issues on ethical practice in ecosystem #ethics
“The ability to obtain rapid test results allows us to gain a clearer picture of viral infections so that we are able to introduce interventions with greater effectiveness,” explains Daniel Ndima, CEO of CapeBio.